Mice Lacking Hepatic Lipase Are Lean and Protected against Diet-Induced Obesity and Hepatic Steatosis

被引:32
|
作者
Chiu, Harvey K. [1 ]
Qian, Kun [1 ]
Ogimoto, Kayoko [2 ]
Morton, Gregory J. [2 ]
Wisse, Brent E. [2 ]
Agrawal, Nalini [1 ]
McDonald, Thomas O. [2 ]
Schwartz, Michael W. [2 ]
Dichek, Helen L. [1 ]
机构
[1] Univ Washington, Dept Pediat, Seattle, WA 98195 USA
[2] Univ Washington, Dept Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
STEAROYL-COA DESATURASE-1; MULTIFACTORIAL MOUSE MODEL; NERVOUS-SYSTEM CONTROL; LIPOPROTEIN METABOLISM; INTRAABDOMINAL FAT; DEFICIENT MICE; WEIGHT-LOSS; FOOD-INTAKE; RECEPTOR; ATHEROSCLEROSIS;
D O I
10.1210/en.2009-1100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hepatic lipase (HL)-mediated lipoprotein hydrolysis provides free fatty acids for energy, storage, and nutrient signaling and may play a role in energy homeostasis. Because HL-activity increases with increased visceral fat, we hypothesized that increased HL-activity favors weight gain and obesity and consequently, that HL deficiency would reduce body fat stores and protect against diet-induced obesity. To test this hypothesis, we compared wild-type mice (with endogenous HL) and mice genetically deficient in HL with respect to daily body weight and food intake, body composition, and adipocyte size on both chow and high-fat (HF) diets. Key determinants of energy expenditure, including rate of oxygen consumption, heat production, and locomotor activity, were measured by indirect calorimetry. HL-deficient mice exhibited reduced weight gain on both diets (by 32%, chow; by 50%, HF; both P < 0.0001, n = 6-7 per genotype), effects that were associated with reduced average daily food intake (by 22-30% on both diets, P < 0.0001) and a modest increase in the rate of oxygen consumption (by 25%, P < 0.003) during the light cycle. Moreover, in mice fed the HF diet, HL deficiency reduced both body fat (by 30%, P < 0.0001) and adipocyte size (by 53%, P < 0.01) and fully prevented the development of hepatic steatosis. Also, HL deficiency reduced adipose tissue macrophage content, consistent with reduced inflammation and a lean phenotype. Our results demonstrate that in mice, HL deficiency protects against diet-induced obesity and its hepatic sequelae. Inhibition of HL-activity may therefore have value in the prevention and/or treatment of obesity. (Endocrinology 151: 993-1001, 2010)
引用
收藏
页码:993 / 1001
页数:9
相关论文
共 50 条
  • [1] Bavachin protects against diet-induced hepatic steatosis and obesity in mice
    Wei, Xiang
    Lin, Li
    Yuan, Qian-qian
    Wang, Xiu-yun
    Zhang, Qing
    Zhang, Xiao-min
    Tang, Ke-chao
    Guo, Man-yu
    Dong, Ting-yu
    Han, Wei
    Huang, Da-ke
    Qi, Yin-liang
    Zhang, Mei
    Zhang, Hua-bing
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (07) : 1416 - 1428
  • [2] Bavachin protects against diet-induced hepatic steatosis and obesity in mice
    Xiang Wei
    Li Lin
    Qian-qian Yuan
    Xiu-yun Wang
    Qing Zhang
    Xiao-min Zhang
    Ke-chao Tang
    Man-yu Guo
    Ting-yu Dong
    Wei Han
    Da-ke Huang
    Yin-liang Qi
    Mei Zhang
    Hua-bing Zhang
    Acta Pharmacologica Sinica, 2023, 44 : 1416 - 1428
  • [3] Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis
    Bernhard Radlinger
    Claudia Ress
    Sabrina Folie
    Karin Salzmann
    Ana Lechuga
    Bernhard Weiss
    Willi Salvenmoser
    Michael Graber
    Jakob Hirsch
    Johannes Holfeld
    Christian Kremser
    Patrizia Moser
    Gabriele Staudacher
    Tomas Jelenik
    Michael Roden
    Herbert Tilg
    Susanne Kaser
    Diabetologia, 2023, 66 : 754 - 767
  • [4] Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis
    Radlinger, Bernhard
    Ress, Claudia
    Folie, Sabrina
    Salzmann, Karin
    Lechuga, Ana
    Weiss, Bernhard
    Salvenmoser, Willi
    Graber, Michael
    Hirsch, Jakob
    Holfeld, Johannes
    Kremser, Christian
    Moser, Patrizia
    Staudacher, Gabriele
    Jelenik, Tomas
    Roden, Michael
    Tilg, Herbert
    Kaser, Susanne
    DIABETOLOGIA, 2023, 66 (04) : 754 - 767
  • [5] Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice
    Krumm, Christopher S.
    Xu, Xu
    Bare, Curtis J.
    Holman, Corey D.
    Kersten, Sander
    Dow, Lukas E.
    Lee, Ann-Hwee
    Cohen, David E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 297 (01)
  • [6] Propolis Decrease Diet-Induced Hepatic Steatosis in Mice
    Herrera, Christian L.
    Fritz, Osvaldo
    Montenegro, Gloria
    Alvear, Marysol
    del Sol, Mariano
    Salazar, Luis A.
    INTERNATIONAL JOURNAL OF MORPHOLOGY, 2010, 28 (01): : 75 - 84
  • [7] Mice deficient in CD18 are protected against diet-induced steatohepatitis, but at the expense of increased hepatic steatosis
    Pierce, Andrew
    Siao, Kevin
    Mattis, Aras N.
    Maher, Jacquelyn J.
    HEPATOLOGY, 2013, 58 : 527A - 527A
  • [8] Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity Rats
    Li, Mao
    Liu, Rui
    GASTROENTEROLOGY, 2015, 148 (04) : S1056 - S1056
  • [9] Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats
    Li, Mao
    Ye, Ting
    Wang, Xiao-Xia
    Li, Xian
    Qiang, Ou
    Yu, Tao
    Tang, Cheng-Wei
    Liu, Rui
    PLOS ONE, 2016, 11 (03):
  • [10] Empagliflozin protects from diet-induced obesity, insulin resistance and hepatic steatosis in mice
    Radlinger, B.
    Ress, C.
    Folie, S.
    Salzmann, K.
    Salvenmoser, W.
    Graber, M.
    Hirsch, J.
    Holfeld, J.
    Kremser, C.
    Moser, P.
    Staudacher, G.
    Jelenik, T.
    Roden, M.
    Tilg, H.
    Kaser, S.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S295 - S295